Allam Mohamed Farouk
Department of Preventive Medicine and Public Health, Faculty of Medicine, University of Cordoba, Spain.
Cent Eur J Public Health. 2016 Sep;24(3):245-247. doi: 10.21101/cejph.a4475.
Over the last decade, the possible association between underarm deodorants/ antiperspirants use and breast cancer risk has raised important interest in the scientific community. The objective of our systematic review is to estimate the pooled risk of deodorants/antiperspirants use for breast cancer.
All observational studies that evaluated the association between breast cancer risk and deodorants/antiperspirants use were reviewed. We have only identified two case-control studies, carried out between 2002 and 2006.
The first study was conducted in USA and investigated the possible relationship between use of products applied for underarm perspiration and the risk for breast cancer in women aged 20-74 years. This population-based case-control study gathered information by in-person interview. The second study was conducted in Iraq and investigated the possible relationship between use of antiperspirants and the risk for breast cancer in women attending a teaching hospital. This study also gathered information by in-person interview. There was no risk of antiperspirants use in the pooled risk (odds ratio 0.40, 95% confidence interval 0.35-0.46).
Our comprehensive search has identified an insufficient number of studies to conduct a quantitative review and obtain reliable results. Further prospective studies are strongly needed.
在过去十年中,使用腋下除臭剂/止汗剂与乳腺癌风险之间可能存在的关联引起了科学界的高度关注。我们系统评价的目的是估计使用除臭剂/止汗剂患乳腺癌的综合风险。
对所有评估乳腺癌风险与使用除臭剂/止汗剂之间关联的观察性研究进行了综述。我们仅确定了2002年至2006年间开展的两项病例对照研究。
第一项研究在美国进行,调查了20至74岁女性使用腋下止汗产品与患乳腺癌风险之间的可能关系。这项基于人群的病例对照研究通过面对面访谈收集信息。第二项研究在伊拉克进行,调查了在一家教学医院就诊的女性使用止汗剂与患乳腺癌风险之间的可能关系。这项研究同样通过面对面访谈收集信息。综合风险中使用止汗剂不存在风险(比值比0.40,95%置信区间0.35 - 0.46)。
我们全面的检索发现,开展定量综述并获得可靠结果的研究数量不足。强烈需要进一步开展前瞻性研究。